Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders, Diffuse Large B-Cell Lymphoma Type, in a Patient with Behcet's Disease Treated with Cyclosporine A

被引:1
|
作者
Urano, Yuka [1 ]
Ohe, Rintaro [1 ]
Yamada, Akane [2 ]
Kabasawa, Takanobu [1 ]
Suzuki, Kazushi [1 ]
Kitaoka, Takumi [1 ]
Tamazawa, Nobuyuki [1 ]
Aung, Naing Ye [1 ]
Utsunomiya, Aya [1 ]
Toubai, Tomomi [2 ]
Ishizawa, Kenichi [2 ]
机构
[1] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata, Japan
[2] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata, Japan
来源
CASE REPORTS IN ONCOLOGY | 2020年 / 13卷 / 03期
基金
日本学术振兴会;
关键词
Behcet's disease; Cyclosporine A; Lymph node; Diffuse large B-cell lymphoma; Epstein-Barr virus; MALIGNANCY; TACROLIMUS;
D O I
10.1159/000510362
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 40-year-old man had been treated for Behcet's disease (BD) with cyclosporine A (CsA) for 14 years. He presented multiple lymphadenopathies with fever. Histological examination of surgical biopsy showed other iatrogenic immunodeficiency-associated lymphoproliferative disorders, diffuse large B-cell lymphoma type with positivity for Epstein-Barr virus encoding RNA-1 (EBER-1). BCL2-IgH, BCL6-IgH, and MYC-IgH translocations were not detected. CsA was stopped, and R-CHOP therapy was initiated. However, his lymphoma was chemotherapy resistant and rapidly progressed. To the best of our knowledge, this is the first case of diffuse large B-cell lymphoma that occurred in a BD patient treated with CsA reported in English. Both BD and CsA are associated with the pathogenesis of lymphoma. We also describe extremely rare cases in the form of a literature review. (c) 2020 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:1145 / 1151
页数:7
相关论文
共 50 条
  • [31] Type 2 diabetic patient with a foot ulcer as initial manifestation of diffuse large B-cell lymphoma: A case report
    Iacopi, Elisabetta
    Coppelli, Alberto
    Goretti, Chiara
    Loggini, Barbara
    Piaggesi, Alberto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 115 : 130 - 132
  • [32] Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome
    Xu, WenLing
    Zhou, LeiLei
    Qin, RuJuan
    Tang, HuaRong
    Shen, HuiLing
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (04) : 313 - 319
  • [33] Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis
    Xi Li
    Yan Duan
    Yuxia Hao
    BMC Medical Genomics, 14
  • [34] Secondary Epstein-Barr virus-associated angioimmunoblastic T-cell lymphoma in a patient with diffuse large B-cell lymphoma: report of a case and review of literature
    Yang, Yonggong
    Xu, Peipei
    Wang, Fan
    Fan, Xiangshan
    Ouyang, Jian
    Chen, Bing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 1877 - 1881
  • [35] Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis
    Li, Xi
    Duan, Yan
    Hao, Yuxia
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [36] Epstein-Barr Virus-positive Intestinal Diffuse Large B-cell Lymphoma in a Japanese Patient with Celiac Disease: First Reported Case and a Literature Review
    Ishibashi, Hideki
    Imakiire, So
    Goto, Maki
    Nomaru, Ryohei
    Shibata, Mamoru
    Matsuoka, Hiroki
    Yasuda, Hideki
    Yamashima, Tomomi
    Sakisaka, Hideto
    Tanabe, Taro
    Matsuoka, Satoshi
    Kuno, Nobuaki
    Abe, Koichi
    Funakoshi, Sadahiro
    Takamatsu, Yasushi
    Hirai, Fumihito
    Takeshita, Morishige
    INTERNAL MEDICINE, 2022, 61 (03) : 329 - 334
  • [37] EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjogren's syndrome and membranous glomerulonephritis
    Kim, Chang Seong
    Choi, Yoo Duk
    Choi, Joon Seok
    Bae, Eun Hui
    Ma, Seong Kwon
    Kim, Soo Wan
    BMC NEPHROLOGY, 2012, 13
  • [38] Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab
    Korsos, Victoria
    Vallee, Alexis
    Rys, Ryan
    Probst, Stephan
    Dmitrienko, Svetlana
    Decaluwe, Helene
    Johnson, Nathalie A.
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1256 - 1260
  • [39] Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome
    Kojima, Y
    Tsurumi, H
    Goto, N
    Shimizu, M
    Kasahara, S
    Yamada, T
    Kanemura, N
    Hara, T
    Sawada, M
    Saio, M
    Yamada, T
    Takahashi, T
    Tomita, E
    Takami, T
    Moriwaki, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (06) : 465 - 472
  • [40] Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma
    Maegawa, Saori
    Kuroda, Junya
    Kobayashi, Tsutomu
    Fuchida, Shinichi
    Kawata, Eri
    Kamitsuji, Yuri
    Tsutsumi, Yasuhiko
    Iwai, Toshiki
    Nakao, Mitsushige
    Kaneko, Hiroto
    Uoshima, Nobuhiko
    Shimazaki, Chihiro
    Kobayashi, Yutaka
    Horiike, Shigeo
    Yamamoto, Aihiro
    Kawahito, Yutaka
    Taniwaki, Masafumi
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 785 - 788